Abacus Parenteral Drugs Limited (APDL) is the largest manufacturer of parenteral medicines in East Africa. Established in 2006, the company began commercial production in 2009 and has since grown into a key player in the regional pharmaceutical industry. APDL plays a vital role in strengthening local and regional access to safe, affordable, and high-quality sterile medical products, contributing to improved healthcare delivery and reduced dependence on imports.

The company operates a modern, 11,500-square-meter manufacturing facility situated on 36 acres of land, providing significant capacity for current operations and future expansion. APDL produces a broad portfolio of sterile products, including intravenous (IV) fluids, ear, eye, and nose drops, sterile water for injection, and other injectable medicines. Its production processes are supported by advanced blow-fill-seal technology, which integrates bottle formation, filling, and sealing in a single automated stage, significantly reducing contamination risks and ensuring high product safety and quality standards.

APDL’s operations are driven by a skilled workforce of over 200 qualified and experienced professionals across various technical and administrative disciplines. By combining modern infrastructure, innovative manufacturing technologies, and specialized expertise, the company maintains high levels of efficiency, compliance, and reliability, positioning itself as a trusted supplier of essential pharmaceutical products within Uganda and the wider East African region.